These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25837457)

  • 41. [Sudden cardiac death in young athletes--causes, prevention and treatment].
    Zeller L; Nechushtan A; Kobal SL; Constantini N
    Harefuah; 2010 Aug; 149(8):515-8, 550. PubMed ID: 21341431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delayed hyperenhancement magnetic resonance imaging for sudden cardiac death risk stratification in hypertrophic cardiomyopathy.
    Efthimiadis GK; Pagourelias ED
    J Am Coll Cardiol; 2009 Dec; 55(1):77. PubMed ID: 20117370
    [No Abstract]   [Full Text] [Related]  

  • 44. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
    Ostman-Smith I
    Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hypertrophic cardiomyopathy and sports activities].
    Brion R
    Rev Prat; 2001 Jun; 51(12 Suppl):S51-3. PubMed ID: 11505870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.
    Maron BJ
    Cardiol Clin; 2007 Aug; 25(3):399-414, vi. PubMed ID: 17961794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic screening and risk assessment in hypertrophic cardiomyopathy.
    MacRae CA; Ellinor PT
    J Am Coll Cardiol; 2004 Dec; 44(12):2326-8. PubMed ID: 15607393
    [No Abstract]   [Full Text] [Related]  

  • 49. Sudden cardiac death in young athletes: trying to find the needle in the haystack.
    Ng B; Maginot KR
    WMJ; 2007 Sep; 106(6):335-42. PubMed ID: 17970016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parents' experiences of having an asymptomatic child diagnosed with hypertrophic cardiomyopathy through family screening.
    Bratt EL; Ostman-Smith I; Sparud-Lundin C; Axelsson BÅ
    Cardiol Young; 2011 Feb; 21(1):8-14. PubMed ID: 20883596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myocardial ischemia on thallium scintigraphy in hypertrophic cardiomyopathy: predictor of sudden cardiac death.
    Haley JH; Miller TD
    Circulation; 2001 Sep; 104(13):E71-1. PubMed ID: 11571257
    [No Abstract]   [Full Text] [Related]  

  • 52. Sudden cardiac death in young athletes.
    Mortazavi M
    Adv Pediatr; 2013; 60(1):201-15. PubMed ID: 24007846
    [No Abstract]   [Full Text] [Related]  

  • 53. Sudden cardiac death due to risperidone therapy in a patient with possible hypertrophic cardiomyopathy.
    Marti V
    Ann Pharmacother; 2005 May; 39(5):973. PubMed ID: 15827070
    [No Abstract]   [Full Text] [Related]  

  • 54. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?
    Maron BJ; Olivotto I; Maron MS
    Eur Heart J; 2006 Aug; 27(16):1895-7. PubMed ID: 16818455
    [No Abstract]   [Full Text] [Related]  

  • 55. Risk of sudden death in end-stage hypertrophic cardiomyopathy.
    Kawarai H; Kajimoto K; Minami Y; Hagiwara N; Kasanuki H
    J Card Fail; 2011 Jun; 17(6):459-64. PubMed ID: 21624733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sudden cardiac death in young athletes.
    Leikin SM; Pierce A; Nelson M
    Dis Mon; 2013 Mar; 59(3):97-101. PubMed ID: 23410670
    [No Abstract]   [Full Text] [Related]  

  • 57. A patient with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Elias TC; Partridge JS; McCorkell SA; Dhesi JK
    BMJ; 2013 Nov; 347():f6910. PubMed ID: 24277340
    [No Abstract]   [Full Text] [Related]  

  • 58. [Asymptomatic hypertrophic myocardiopathy. The arguments in favor of its treatment].
    Penas Lado M; Castro Beiras A
    Rev Esp Cardiol; 1995 Aug; 48(8):522-7. PubMed ID: 7644805
    [No Abstract]   [Full Text] [Related]  

  • 59. The quest for perfection: the contribution of the electrocardiogram to the prevention of sudden death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott P
    Europace; 2009 May; 11(5):548-9. PubMed ID: 19287015
    [No Abstract]   [Full Text] [Related]  

  • 60. Sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Fananapazir L
    Circulation; 1992 Jan; 85(1 Suppl):I57-63. PubMed ID: 1728506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.